astrazeneca
Latest from astrazeneca
European, Indian pharma stocks decline after Trump again threatens tariffs
US-USA-TRUMP-TARIFFS-PHARMACEUTICALS:European, Indian pharma stocks decline after Trump again threatens tariffs
Updated on Apr 09, 2025 01:09 PM IST
Reuters |
The great Indian debate on national champions
A growth path that is overly dependent on a few oligarchs may not answer the needs of a large and complex democracy
Published on Dec 02, 2024 08:15 PM IST
Drug giants eye China for deals despite growing Sino-US tensions
HEALTH-CHINA/M
Published on Jul 23, 2024 07:43 AM IST
Reuters |
Perils of promoting an anti-vaccination scare
Unless all of them play their roles with conviction and commitment, a confused public will be sceptical of science and suspicious of public health interventions
Published on May 28, 2024 10:07 PM IST
K Srinath Reddy
AstraZeneca aims for $80 billion in total revenue by 2030
AstraZeneca had reported total revenue of $45.81 billion last year and earlier expected to launch at least 15 new medicines between 2023 and 2030.
Published on May 21, 2024 01:58 PM IST
Reuters |